Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
Hongxin Huang(Southern Medical University), Zhili Rong(Southern Medical University)
Cited by 52
Related Papers
MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression <i>in vivo</i>
|Nucleic Acids Research|2021|54
An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
|PLoS ONE|2014|33
OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients
|Protein & Cell|2021|16
Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
|Frontiers in Oncology|2024|14
Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids
|Journal of Investigative Dermatology|2023|12